Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 2
1992 1
1995 3
1999 1
2000 1
2002 1
2003 1
2004 2
2006 1
2007 4
2008 9
2009 3
2010 4
2011 4
2012 3
2013 4
2014 5
2015 5
2016 4
2017 5
2018 12
2019 10
2020 10
2021 13
2022 12
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies.
Savarirayan R, De Bergua JM, Arundel P, McDevitt H, Cormier-Daire V, Saraff V, Skae M, Delgado B, Leiva-Gea A, Santos-Simarro F, Salles JP, Nicolino M, Rossi M, Kannu P, Bober MB, Phillips J 3rd, Saal H, Harmatz P, Burren C, Gotway G, Cho T, Muslimova E, Weng R, Rogoff D, Hoover-Fong J, Irving M. Savarirayan R, et al. Among authors: de bergua jm. Ther Adv Musculoskelet Dis. 2022 Mar 21;14:1759720X221084848. doi: 10.1177/1759720X221084848. eCollection 2022. Ther Adv Musculoskelet Dis. 2022. PMID: 35342457 Free PMC article.
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma.
Nowakowski GS, Chiappella A, Gascoyne RD, Scott DW, Zhang Q, Jurczak W, Özcan M, Hong X, Zhu J, Jin J, Belada D, Bergua JM, Piazza F, Mócikova H, Molinari AL, Yoon DH, Cavallo F, Tani M, Yamamoto K, Izutsu K, Kato K, Czuczman M, Hersey S, Kilcoyne A, Russo J, Hudak K, Zhang J, Wade S, Witzig TE, Vitolo U. Nowakowski GS, et al. Among authors: bergua jm. J Clin Oncol. 2021 Apr 20;39(12):1317-1328. doi: 10.1200/JCO.20.01366. Epub 2021 Feb 23. J Clin Oncol. 2021. PMID: 33621109 Free PMC article. Clinical Trial.
Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry.
Sargas C, Ayala R, Larráyoz MJ, Chillón MC, Carrillo-Cruz E, Bilbao-Sieyro C, Prados de la Torre E, Martínez-Cuadrón D, Rodríguez-Veiga R, Boluda B, Gil C, Bernal T, Bergua JM, Algarra L, Tormo M, Martínez-Sánchez P, Soria E, Serrano J, Alonso-Domínguez JM, García-Boyero R, Amigo ML, Herrera-Puente P, Sayas MJ, Lavilla-Rubira E, Martínez-López J, Calasanz MJ, García-Sanz R, Pérez-Simón JA, Gómez-Casares MT, Sánchez-García J, Barragán E, Montesinos P, On Behalf Of Pethema Group. Sargas C, et al. Among authors: bergua jm. Cancers (Basel). 2023 Jan 10;15(2):438. doi: 10.3390/cancers15020438. Cancers (Basel). 2023. PMID: 36672386 Free PMC article.
Tutorial: design and fabrication of nanoparticle-based lateral-flow immunoassays.
Parolo C, Sena-Torralba A, Bergua JF, Calucho E, Fuentes-Chust C, Hu L, Rivas L, Álvarez-Diduk R, Nguyen EP, Cinti S, Quesada-González D, Merkoçi A. Parolo C, et al. Among authors: bergua jf. Nat Protoc. 2020 Dec;15(12):3788-3816. doi: 10.1038/s41596-020-0357-x. Epub 2020 Oct 23. Nat Protoc. 2020. PMID: 33097926 Review.
Immunosenescence: limitations of natural killer cell-based cancer immunotherapy.
Tarazona R, Sanchez-Correa B, Casas-Avilés I, Campos C, Pera A, Morgado S, López-Sejas N, Hassouneh F, Bergua JM, Arcos MJ, Bañas H, Casado JG, Durán E, Labella F, Solana R. Tarazona R, et al. Among authors: bergua jm. Cancer Immunol Immunother. 2017 Feb;66(2):233-245. doi: 10.1007/s00262-016-1882-x. Epub 2016 Aug 16. Cancer Immunol Immunother. 2017. PMID: 27530271 Free PMC article. Review.
Nanodiagnostics to Face SARS-CoV-2 and Future Pandemics: From an Idea to the Market and Beyond.
Rosati G, Idili A, Parolo C, Fuentes-Chust C, Calucho E, Hu L, Castro E Silva CC, Rivas L, Nguyen EP, Bergua JF, Alvárez-Diduk R, Muñoz J, Junot C, Penon O, Monferrer D, Delamarche E, Merkoçi A. Rosati G, et al. Among authors: bergua jf. ACS Nano. 2021 Nov 23;15(11):17137-17149. doi: 10.1021/acsnano.1c06839. Epub 2021 Oct 27. ACS Nano. 2021. PMID: 34705433 Free PMC article. Review.
Natural killer cell immunosenescence in acute myeloid leukaemia patients: new targets for immunotherapeutic strategies?
Sanchez-Correa B, Campos C, Pera A, Bergua JM, Arcos MJ, Bañas H, Casado JG, Morgado S, Duran E, Solana R, Tarazona R. Sanchez-Correa B, et al. Among authors: bergua jm. Cancer Immunol Immunother. 2016 Apr;65(4):453-63. doi: 10.1007/s00262-015-1720-6. Epub 2015 Jun 10. Cancer Immunol Immunother. 2016. PMID: 26059279 Free PMC article. Review.
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry.
Martínez-Cuadrón D, Megías-Vericat JE, Gil C, Bernal T, Tormo M, Martínez-Sánchez P, Rodríguez-Medina C, Serrano J, Herrera P, Simón JAP, Sayas MJ, Bergua J, Lavilla-Rubira E, Amigo ML, Benavente C, Lorenzo JLL, Pérez-Encinas MM, Vidriales MB, Colorado M, De Rueda B, García-Boyero R, Marini S, García-Suárez J, López-Pavía M, Gómez-Roncero MI, Noriega V, López A, Labrador J, Cabello A, Sossa C, Algarra L, Stevenazzi M, Solana-Altabella A, Boluda B, Montesinos P. Martínez-Cuadrón D, et al. Among authors: bergua j. Haematologica. 2024 Jan 1;109(1):115-128. doi: 10.3324/haematol.2022.282506. Haematologica. 2024. PMID: 37199127 Free PMC article.
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
Sargas C, Ayala R, Larráyoz MJ, Chillón MC, Rodriguez-Arboli E, Bilbao C, Prados de la Torre E, Martínez-Cuadrón D, Rodríguez-Veiga R, Boluda B, Gil C, Bernal T, Bergua J, Algarra L, Tormo M, Martínez-Sánchez P, Soria E, Serrano J, Alonso-Dominguez JM, García R, Amigo ML, Herrera-Puente P, Sayas MJ, Lavilla-Rubira E, Martínez-López J, Calasanz MJ, García-Sanz R, Pérez-Simón JA, Gómez Casares MT, Sánchez-García J, Barragán E, Montesinos P; PETHEMA cooperative study group. Sargas C, et al. Among authors: bergua j. Blood Cancer J. 2023 May 12;13(1):77. doi: 10.1038/s41408-023-00835-5. Blood Cancer J. 2023. PMID: 37173322 Free PMC article.
106 results